The telehealth company Hims & Hers is adding Zepbound and generic liraglutide to its offering of weight-loss drugs.
Hims & Hers stirred the weight-loss waters by announcing it now offers prescriptions for Zepbound, Eli Lilly’s premium GLP-1 ...
The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.
Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical ...
Directors of five NIH institutes have been placed on administrative leave or offered new assignments as part of sweeping HHS ...
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain ...
For a variety of reasons, Globe Food contributor Kara Baskin took the leap and started Zepbound. But first she worried: "What ...
The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...
The state’s second-largest insurer is grappling with heightened health care spending and a market that is increasingly unable ...
As Novo Nordisk A/S shares head for their worst month in more than two decades, the days when the Danish drugmaker was valued at more than $600 billion are becoming a distant memory.
Woman's World on MSN7d
Ozempic Prices Are Soaring-Experts Reveal 5 Ways to Save on GLP-1 Meds"Now the only option will be to find the best possible deal on traditional forms of the drugs," says NYU's Alexandra Sowa, MD ...
A large majority of older Americans feel that health insurance – including Medicare – should cover anti-obesity medications, according to a new University of Michigan study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback